Amyloid imaging in late life depressio
- Conditions
- ate life depressionTherapeutic area: Psychiatry and Psychology [F] - Psychological processes [F02]
- Registration Number
- EUCTR2009-018064-95-BE
- Lead Sponsor
- niversity of Leuven
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 120
1. older than 60 years
2. a mjor depressive disorder according to DSM IV criteria
3. a MMSE> ou = 20
4. not primarily referred for assessment of cognitive impairment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 100
1. anothermajor psychiatric illness
2. alcohol or drug dependence
3. neurologic illness, including stroke, transient ischemic attacks and dementia
4. illness or medication precluding cognitive testing
5. metal implants precluding MRI. Information on prior episodes and age of onset will be obtained from patients and from caregivers.
6. ECT in the last 3 months prior to inclusion.
7. Use of steroids within the last 3 months or other medication interfering with HPA axis.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method